{"id":"W3187178237","doi":"10.1017/cjn.2019.122","title":"P.022 Myasthenia gravis following dabrafenib and trametinib for metastatic melanoma","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Trametinib; Dabrafenib; Medicine; Myasthenia gravis; MEK inhibitor; Pyridostigmine; Melanoma; Internal medicine; Gastroenterology; MAPK/ERK pathway; Cancer research; Vemurafenib; Kinase; Metastatic melanoma; Biology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002189254,0.0003611534,0.0002923651,0.0003896159,0.0007327854,0.0005134871,0.0003837742,0.001530255,0.008080568],"category_scores_gemma":[0.001092815,0.0001511767,0.0004206281,0.0002669488,0.0004180685,0.0004144672,0.0003250411,0.001229207,0.001635053],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006604213,"about_ca_system_score_gemma":0.0004055057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001551637,"about_ca_topic_score_gemma":0.001911488,"domain_scores_codex":[0.9997889,0.00003008668,0.00001591292,0.00002717457,0.00004438452,0.00009345524],"domain_scores_gemma":[0.9994892,0.0001193035,0.0001551339,0.00002252752,0.0000516813,0.000162084],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.0004499347,0.0001613846,0.08844201,0.00009264292,0.00005590928,0.8867908,0.0001501438,0.0001482845,0.001556962,0.0004628578,0.00566249,0.01602656],"study_design_scores_gemma":[0.0001226187,0.0005958696,0.1018729,0.0001010255,0.00005076594,0.8855639,0.0001573739,0.001030777,0.0006810671,0.0004094173,0.009399859,0.00001437515],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9277465,0.007135122,0.0007330562,0.006781407,0.000649344,0.0001111294,0.0002213491,0.0001395824,0.05648247],"genre_scores_gemma":[0.993697,0.0006069763,0.0001532629,0.0009404728,0.0006930102,0.00001293774,0.0001127823,0.000009076244,0.003774557],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008080568,"threshold_uncertainty_score":0.0270322,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04194767816253712,"score_gpt":0.3206121343342226,"score_spread":0.2786644561716854,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}